1.77
price up icon0.57%   0.01
after-market After Hours: 1.78 0.01 +0.56%
loading
Nls Pharmaceutics Ltd stock is traded at $1.77, with a volume of 80,328. It is up +0.57% in the last 24 hours and down -17.67% over the past month. NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
See More
Previous Close:
$1.76
Open:
$1.81
24h Volume:
80,328
Relative Volume:
0.20
Market Cap:
$6.37M
Revenue:
-
Net Income/Loss:
$-15.47M
P/E Ratio:
-3.54
EPS:
-0.5
Net Cash Flow:
$-13.51M
1W Performance:
-7.81%
1M Performance:
-17.67%
6M Performance:
+31.11%
1Y Performance:
-60.22%
1-Day Range:
Value
$1.7001
$1.8516
1-Week Range:
Value
$1.7001
$1.93
52-Week Range:
Value
$1.30
$5.6432

Nls Pharmaceutics Ltd Stock (NLSP) Company Profile

Name
Name
Nls Pharmaceutics Ltd
Name
Phone
-
Name
Address
-
Name
Employee
1
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
NLSP's Discussions on Twitter

Compare NLSP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NLSP
Nls Pharmaceutics Ltd
1.77 7.48M 0 -15.47M -13.51M -0.50
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Nls Pharmaceutics Ltd Stock (NLSP) Latest News

pulisher
11:05 AM

Why NLS Pharmaceutics AG Equity Warrant stock is recommended by analystsJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com

11:05 AM
pulisher
10:54 AM

Regression analysis insights on NLS Pharmaceutics AG Equity Warrant performanceJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com

10:54 AM
pulisher
10:06 AM

Combining machine learning predictions for NLS Pharmaceutics AGJuly 2025 Institutional & Growth Focused Entry Reports - newser.com

10:06 AM
pulisher
09:08 AM

What indicators show strength in NLS Pharmaceutics AG Equity WarrantJuly 2025 Sentiment & Stock Portfolio Risk Management - newser.com

09:08 AM
pulisher
09:03 AM

Will NLS Pharmaceutics AG Equity Warrant stock outperform value stocksDollar Strength & High Return Stock Watch Alerts - newser.com

09:03 AM
pulisher
08:04 AM

Can a trend reversal in NLS Pharmaceutics AG lead to recoveryWeekly Stock Analysis & Free Community Supported Trade Ideas - newser.com

08:04 AM
pulisher
03:16 AM

Is NLS Pharmaceutics AG a candidate for recovery playEarnings Overview Summary & Smart Money Movement Alerts - newser.com

03:16 AM
pulisher
01:02 AM

Analyzing recovery setups for NLS Pharmaceutics AG Equity Warrant investors2025 Trading Volume Trends & Precise Trade Entry Recommendations - newser.com

01:02 AM
pulisher
Oct 10, 2025

Will NLS Pharmaceutics AG Equity Warrant rebound enough to break evenGold Moves & Real-Time Stock Entry Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

NLS Pharmaceutics files financial statements related to Kadimastem merger - Investing.com India

Oct 10, 2025
pulisher
Oct 10, 2025

NLS Pharmaceutics Announces Strategic Merger with Kadimastem - TipRanks

Oct 10, 2025
pulisher
Oct 10, 2025

NLS Pharmaceutics files financial statements related to Kadimastem merger By Investing.com - Investing.com UK

Oct 10, 2025
pulisher
Oct 10, 2025

Will NLS Pharmaceutics AG Equity Warrant bounce back from current supportQuarterly Trade Report & Real-Time Volume Analysis Alerts - newser.com

Oct 10, 2025
pulisher
Oct 05, 2025

What’s next for NLS Pharmaceutics AG Equity Warrant stock priceQuarterly Earnings Report & Reliable Price Breakout Signals - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

What to expect from NLS Pharmaceutics AG Equity Warrant in the next 30 daysJuly 2025 Rallies & AI Driven Stock Reports - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How NLS Pharmaceutics AG stock reacts to Fed rate cutsJuly 2025 Closing Moves & Technical Analysis for Trade Confirmation - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Is NLS Pharmaceutics AG stock positioned well for digital economyWeekly Trend Recap & Technical Pattern Based Signals - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

NLS Pharmaceutics AG Stock Analysis and ForecastPortfolio Risk Assessment & Identify Safe Investments - earlytimes.in

Oct 02, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics Approve Merger with Kadimastem - citybiz

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics stock tumbles after merger approval with Kadimastem By Investing.com - Investing.com Nigeria

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics stock tumbles after merger approval with Kadimastem - Investing.com

Sep 30, 2025
pulisher
Sep 30, 2025

NLSP Stock Faces Highs and Lows: A Closer Look - StocksToTrade

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics Stock: What’s Next? - timothysykes.com

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics shareholders approve merger with Kadimastem By Investing.com - Investing.com Australia

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics Shareholders Approve Merger with Kadimastem - TipRanks

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics shareholders approve merger with Kadimastem - Investing.com India

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics shareholders approve merger with Kadimastem and related proposals at extraordinary general meeting - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

84.4% Ownership Stake: Kadimastem-NLS Pharma Merger Creates NewCelX with ALS and Diabetes Pipeline - Stock Titan

Sep 30, 2025
pulisher
Sep 29, 2025

Is NLS Pharmaceutics AG stock dividend yield sustainableWeekly Risk Summary & High Yield Equity Trading Tips - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

NLS Pharmaceutics (NASDAQ:NLSP) Rating Increased to Hold at Wall Street Zen - Defense World

Sep 29, 2025
pulisher
Sep 29, 2025

Visual trend scoring systems applied to NLS Pharmaceutics AG Equity WarrantJuly 2025 Price Swings & Accurate Buy Signal Alerts - newser.com

Sep 29, 2025
pulisher
Sep 22, 2025

Using economic indicators to assess NLS Pharmaceutics AG Equity Warrant potentialWeekly Risk Summary & Scalable Portfolio Growth Methods - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Is NLS Pharmaceutics AG stock ready for a breakoutTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Market reaction to NLS Pharmaceutics AG Equity Warrant’s recent newsJuly 2025 Breakouts & Expert Approved Momentum Trade Ideas - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Custom strategy builders for tracking NLS Pharmaceutics AGMarket Performance Report & AI Enhanced Market Trend Forecasts - newser.com

Sep 21, 2025
pulisher
Sep 20, 2025

Rally Mode: Does NLS Pharmaceutics AG stock benefit from AI growthPrice Action & Low Risk Growth Stock Ideas - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

NLS Pharmaceutics Engages New Accounting Firm After Marcum’s Resignation - The Globe and Mail

Sep 20, 2025
pulisher
Sep 20, 2025

What data driven models say about NLS Pharmaceutics AG Equity Warrant’s futureJuly 2025 Analyst Calls & Weekly Stock Breakout Alerts - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

What the charts say about NLS Pharmaceutics AG Equity Warrant todayNew Guidance & Free Accurate Trade Setup Notifications - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

How moving averages guide NLS Pharmaceutics AG tradingTreasury Yields & High Accuracy Trade Signal Alerts - newser.com

Sep 20, 2025
pulisher
Sep 19, 2025

Chart based exit strategy for NLS Pharmaceutics AGProfit Target & Intraday High Probability Setup Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Is NLS Pharmaceutics AG stock reversal real or fakeQuarterly Portfolio Summary & Smart Swing Trading Alerts - newser.com

Sep 19, 2025

Nls Pharmaceutics Ltd Stock (NLSP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):